Agency Forms Undergoing Paperwork Reduction Act Review, 52011-52012 [2014-20718]
Download as PDF
52011
Federal Register / Vol. 79, No. 169 / Tuesday, September 2, 2014 / Notices
conducted annually over a three-year
period, beginning in FY15.
Likely Respondents: Survey
respondents will consist of Medicare
beneficiaries, providers, suppliers, or
their representatives who participated
in a hearing before an OMHA ALJ.
OMHA will draw a representative, non-
redundant sample of appellants whose
cases have been closed in the last six
months.
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Number of
respondents
Number
responses per
respondent
Average
burden per
response
(in hours)
Total burden
hours
Type of respondent
Form name
Charged at rate of Healthcare Providers and Suppliers
Charged at rate of Beneficiaries .....................................
Form A ................
Form A ................
240
160
1
1
11/60
11/60
44
29
Total .........................................................................
.............................
400
1
11/60
73
OS specifically requests comments on
(1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Health Services Corps Scholarship
Program (42 U.S.C. 250(B)(1)(A))’’ and
‘‘National Research Service Award
Program (42 U.S.C. 288(c)(4)(B)).’’ This
interest rate will be applied to overdue
debt until the Department of Health and
Human Services publishes a revision.
Darius Taylor,
Information Collection Clearance Officer.
BILLING CODE 4150–04–P
Dated: August 11, 2014.
Teresa Miranda,
Director, Financial Management Policy
Division.
[FR Doc. 2014–20773 Filed 8–29–14; 8:45 am]
[FR Doc. 2014–20769 Filed 8–29–14; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4150–46–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
mstockstill on DSK4VPTVN1PROD with NOTICES
Notice of Interest Rate on Overdue
Debts
Section 30.18 of the Department of
Health and Human Services’ claims
collection regulations (45 CFR Part 30)
provides that the Secretary shall charge
an annual rate of interest, which is
determined and fixed by the Secretary
of the Treasury after considering private
consumer rates of interest on the date
that the Department of Health and
Human Services becomes entitled to
recovery. The rate cannot be lower than
the Department of Treasury’s current
value of funds rate or the applicable rate
determined from the ‘‘Schedule of
Certified Interest Rates with Range of
Maturities’’ unless the Secretary waives
interest in whole or part, or a different
rate is prescribed by statute, contract, or
repayment agreement. The Secretary of
the Treasury may revise this rate
quarterly. The Department of Health and
Human Services publishes this rate in
the Federal Register.
The current rate of 103⁄8%, as fixed by
the Secretary of the Treasury, is certified
for the quarter ended June 30, 2014.
This rate is based on the Interest Rates
for Specific Legislation, ‘‘National
VerDate Mar<15>2010
16:57 Aug 29, 2014
Jkt 232001
Decision To Evaluate a Petition To
Designate a Class of Employees From
the Dow Chemical Co. Facility in
Walnut Creek, California (Also Known
as Pittsburg, CA), To Be Included in
the Special Exposure Cohort
Period of Employment: January 1,
1947 through December 31, 1957.
FOR FURTHER INFORMATION CONTACT:
Stuart L. Hinnefeld, Director, Division
of Compensation Analysis and Support,
National Institute for Occupational
Safety and Health, 1090 Tusculum
Avenue, MS C–46, Cincinnati, OH
45226–1938, Telephone 877–222–7570.
Information requests can also be
submitted by email to DCAS@CDC.GOV.
John Howard,
Director, National Institute for Occupational
Safety and Health.
[FR Doc. 2014–20740 Filed 8–29–14; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–14–0800]
National Institute for
Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention, Department of Health
and Human Services.
ACTION: Notice.
AGENCY:
NIOSH gives notice as
required by 42 CFR 83.12(e) of a
decision to evaluate a petition to
designate a class of employees from the
Dow Chemical Co. facility in Walnut
Creek, California (also known as
Pittsburg, CA), to be included in the
Special Exposure Cohort under the
Energy Employees Occupational Illness
Compensation Program Act of 2000. The
initial proposed definition for the class
being evaluated, subject to revision as
warranted by the evaluation, is as
follows:
Facility: Dow Chemical Co. facility.
Location: Walnut Creek, California
(also known as Pittsburg, CA).
Job Titles and/or Job Duties: All
employees who worked in any area.
SUMMARY:
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
E:\FR\FM\02SEN1.SGM
02SEN1
52012
Federal Register / Vol. 79, No. 169 / Tuesday, September 2, 2014 / Notices
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
Focus Group Testing to Effectively
Plan and Tailor Cancer Prevention and
Control Communication Campaigns
(OMB No. 0920–0800, exp. 11/30/
2014)—Extension—National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The mission of the CDC’s Division of
Cancer Prevention and Control (DCPC)
is to reduce the burden of cancer in the
United States through cancer
prevention, reduction of risk, early
detection, better treatment, and
improved quality of life for cancer
survivors. Toward this end, the DCPC
supports the scientific development,
implementation, and evaluation of
various health communication
campaigns with an emphasis on specific
cancer burdens. This process requires
testing of messages, concepts, and
materials prior to their final
development and dissemination.
Communication campaigns vary
according to the type of cancer, the
qualitative dimensions of the message
described above, and the type of
respondents.
CDC is currently approved to collect
information needed to plan and tailor
cancer communication campaigns (OMB
No. 0920–0800, exp. 11/30/2014), and
seeks OMB approval to extend the
existing generic clearance. No changes
to the scope of the clearance or data
collection methodology are proposed.
There are small decreases in the
annualized estimates for the number of
respondents and burden hours.
Information will be collected
primarily through focus groups, and
will be used to assess numerous
qualitative dimensions of cancer
prevention and control messages,
including, but not limited to,
knowledge, attitudes, beliefs, behavioral
intentions, information needs and
sources, and compliance to
recommended screening intervals.
Insights gained from the focus groups
will assist in the development and/or
refinement of future campaign messages
and materials.
DCPC plans to conduct or sponsor up
to 80 focus groups per year over a threeyear period. An average of 10
respondents will participate in each
focus group discussion. Screening will
be conducted to recruit respondents for
specific target audiences, e.g., the
general public or health care providers.
The estimated burden per response for
screening is three minutes. Each focus
group discussion will be facilitated by a
written discussion guide, and will last
approximately two hours. CDC will
submit an information collection
request to OMB for approval of each
focus group activity.
OMB approval is requested for three
years. There are no changes to
information collection purpose or
methodology. There are minor
reductions in the annualized estimates
for the number of respondents and
corresponding burden hours.
Participation is voluntary and there
are no costs to respondents except their
time. The total estimated annualized
burden hours are 1,680.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
General Public ................................................
Screening Form ..............................................
Focus Group Guide ........................................
Screening Form ..............................................
Focus Group Guide ........................................
Health Care Professionals ..............................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–D–0329]
[FR Doc. 2014–20718 Filed 8–29–14; 8:45 am]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Guidance for
Industry on Fees for Human Drug
Compounding Outsourcing Facilities
Under the Federal Food, Drug, and
Cosmetic Act
mstockstill on DSK4VPTVN1PROD with NOTICES
BILLING CODE 4163–18–P
AGENCY:
Food and Drug Administration,
HHS.
VerDate Mar<15>2010
16:57 Aug 29, 2014
Jkt 232001
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
960
480
640
320
ACTION:
1
1
1
1
Average
burden per
response
(in hours)
3/60
2
3/60
2
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995
(the PRA).
DATES: Fax written comments on the
collection of information by October 2,
2014.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
SUMMARY:
E:\FR\FM\02SEN1.SGM
02SEN1
Agencies
[Federal Register Volume 79, Number 169 (Tuesday, September 2, 2014)]
[Notices]
[Pages 52011-52012]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-20718]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-14-0800]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of
[[Page 52012]]
information, including the validity of the methodology and assumptions
used; (c) Enhance the quality, utility, and clarity of the information
to be collected; (d) Minimize the burden of the collection of
information on those who are to respond, including through the use of
appropriate automated, electronic, mechanical, or other technological
collection techniques or other forms of information technology, e.g.,
permitting electronic submission of responses; and (e) Assess
information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
Focus Group Testing to Effectively Plan and Tailor Cancer
Prevention and Control Communication Campaigns (OMB No. 0920-0800, exp.
11/30/2014)--Extension--National Center for Chronic Disease Prevention
and Health Promotion (NCCDPHP), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The mission of the CDC's Division of Cancer Prevention and Control
(DCPC) is to reduce the burden of cancer in the United States through
cancer prevention, reduction of risk, early detection, better
treatment, and improved quality of life for cancer survivors. Toward
this end, the DCPC supports the scientific development, implementation,
and evaluation of various health communication campaigns with an
emphasis on specific cancer burdens. This process requires testing of
messages, concepts, and materials prior to their final development and
dissemination. Communication campaigns vary according to the type of
cancer, the qualitative dimensions of the message described above, and
the type of respondents.
CDC is currently approved to collect information needed to plan and
tailor cancer communication campaigns (OMB No. 0920-0800, exp. 11/30/
2014), and seeks OMB approval to extend the existing generic clearance.
No changes to the scope of the clearance or data collection methodology
are proposed. There are small decreases in the annualized estimates for
the number of respondents and burden hours.
Information will be collected primarily through focus groups, and
will be used to assess numerous qualitative dimensions of cancer
prevention and control messages, including, but not limited to,
knowledge, attitudes, beliefs, behavioral intentions, information needs
and sources, and compliance to recommended screening intervals.
Insights gained from the focus groups will assist in the development
and/or refinement of future campaign messages and materials.
DCPC plans to conduct or sponsor up to 80 focus groups per year
over a three-year period. An average of 10 respondents will participate
in each focus group discussion. Screening will be conducted to recruit
respondents for specific target audiences, e.g., the general public or
health care providers. The estimated burden per response for screening
is three minutes. Each focus group discussion will be facilitated by a
written discussion guide, and will last approximately two hours. CDC
will submit an information collection request to OMB for approval of
each focus group activity.
OMB approval is requested for three years. There are no changes to
information collection purpose or methodology. There are minor
reductions in the annualized estimates for the number of respondents
and corresponding burden hours.
Participation is voluntary and there are no costs to respondents
except their time. The total estimated annualized burden hours are
1,680.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
General Public........................ Screening Form.......... 960 1 3/60
Focus Group Guide....... 480 1 2
Health Care Professionals............. Screening Form.......... 640 1 3/60
Focus Group Guide....... 320 1 2
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-20718 Filed 8-29-14; 8:45 am]
BILLING CODE 4163-18-P